Cube Pharmaceuticals announced that it has received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for nifedipine issued by the State Drug Administration.
立方制药：收到原料药硝苯地平上市申请批准通知书
Cube Pharmaceuticals: Received a notice of approval for the marketing application of the API nifedipine
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.